1-3 of 3
Pierre-Yves Brard
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Divalent Hapten-Peptide Induces Apoptosis in Human Non–Hodgkin Lymphoma Cell Lines Targeted by Anti-CD20 × Anti-Hapten Bispecific Antibodies

Pierre-Yves Brard, Habibe Karacay, Rhona Stein, Robert M. Sharkey, M. Jules Mattes, Chien-Hsing Chang, Edmund A. Rossi, William J. McBride, David M. Goldenberg
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (18): 5564s–5571s.
https://doi.org/10.1158/1078-0432.CCR-07-1204
Published: 17 September 2007
View article titled, A Divalent Hapten-Peptide Induces Apoptosis in Human Non–Hodgkin Lymphoma Cell Lines Targeted by Anti-CD20 × Anti-Hapten Bispecific Antibodies
Open the PDF for A Divalent Hapten-Peptide Induces Apoptosis in Human Non–Hodgkin Lymphoma Cell Lines Targeted by Anti-CD20 × Anti-Hapten Bispecific Antibodies in another window
Journal Articles

Therapeutic Advantage of Pretargeted Radioimmunotherapy Using a Recombinant Bispecific Antibody in a Human Colon Cancer Xenograft

Habibe Karacay, Pierre-Yves Brard, Robert M. Sharkey, Chien-Hsing Chang, Edmund A. Rossi, William J. McBride, Dan R. Ragland, Ivan D. Horak, David M. Goldenberg
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (21): 7879–7885.
https://doi.org/10.1158/1078-0432.CCR-05-1246
Published: 08 November 2005
View article titled, Therapeutic Advantage of Pretargeted Radioimmunotherapy Using a Recombinant Bispecific Antibody in a Human Colon Cancer Xenograft
Open the PDF for Therapeutic Advantage of Pretargeted Radioimmunotherapy Using a Recombinant Bispecific Antibody in a Human Colon Cancer Xenograft in another window
Journal Articles

Pharmacokinetics and Dosimetry Studies for Optimization of Anti-Carcinoembryonic Antigen × Anti-Hapten Bispecific Antibody-mediated Pretargeting of Iodine-131-labeled Hapten in a Phase I Radioimmunotherapy Trial

Françoise Kraeber-Bodéré, Alain Faivre-Chauvet, Ludovic Ferrer, Jean-Philippe Vuillez, Pierre-Yves Brard, Caroline Rousseau, Isabelle Resche, Anne Devillers, Sophie Laffont, Manuel Bardiès, Ken Chang, Robert M. Sharkey, David M. Goldenberg, Jean-François Chatal, Jacques Barbet
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (10): 3973s–3981s.
Published: 01 September 2003
View article titled, Pharmacokinetics and Dosimetry Studies for Optimization of Anti-Carcinoembryonic Antigen × Anti-Hapten Bispecific Antibody-mediated Pretargeting of Iodine-131-labeled Hapten in a Phase I Radioimmunotherapy Trial
Open the PDF for Pharmacokinetics and Dosimetry Studies for Optimization of Anti-Carcinoembryonic Antigen × Anti-Hapten Bispecific Antibody-mediated Pretargeting of Iodine-131-labeled Hapten in a Phase I Radioimmunotherapy Trial in another window